Adj Thifhelimbilu Luvhengo

Thifhelimbilu Luvhengo is a South African clinician-researcher whose work bridges oncology, endocrine surgery, and complications of diabetes within resource-constrained health systems. Affiliated with academic hospitals in Johannesburg, Luvhengo contributes to multidisciplinary research addressing cancers prevalent in the region, including breast, thyroid, melanoma, and cervical malignancies, with attention to local epidemiology and health disparities.

A central research focus lies in diabetic foot sepsis, antimicrobial resistance, and predictors of amputation and mortality. This work integrates clinical epidemiology with machine learning to improve risk stratification and outcomes. Additional contributions examine venous thromboembolism and post-thrombotic syndrome through international registry collaborations, reflecting engagement with global vascular research initiatives.

In oncology, Luvhengo explores precision medicine, immunotherapy, microbiome-based therapeutics, and the therapeutic potential of indigenous medicinal plants, highlighting translational pathways from molecular insights to patient care. Across publications, a consistent strength is the combination of real-world clinical data with innovative analytical approaches to inform context-relevant guidelines and advance equitable cancer and surgical care in South Africa.